Supernus Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Supernus Pharmaceuticals

28/02/2024 24:14

* Supernus Pharmaceuticals Inc  SUPN.OQ  reported quarterly
adjusted earnings of 89 cents​​ per share for the quarter ended
in December, higher than the same quarter last year, when the
company reported EPS of 43 cents.  The mean expectation of
four analysts for the quarter was for earnings of 55 cents per
share. Wall Street expected results to range from 38 cents to 84
cents per share.
    * Revenue fell 1.8% to $164.31 million from a year ago;
analysts
expected $155.03 million. 
    * Supernus Pharmaceuticals Inc's reported EPS for the
quarter was
2 cents​.
    * The company reported quarterly net income of $1.18
million.
    * Supernus Pharmaceuticals Inc shares had risen by 1.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Supernus
Pharmaceuticals Inc is $41.50 
This summary was machine generated from LSEG data February 28 at
12:13 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.55           0.89           Beat
 Sep. 30 2023      0.08           0.24           Beat
 Jun. 30 2023      0.07           -0.02          Missed
 Mar. 31 2023      0.17           0.29           Beat